Project Grant R35GM166148
- Federal Grant Award Summary Dartmouth College received a $2.25 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2029. The award supports the development of novel computational methods to decode disease mechanisms by reconstructing cellular proliferation, differentiation, and migration events from single-cell sequencing data. This...
- Federal Project Grant Summary The National Institute of General Medical Sciences (NIGMS) awarded Dartmouth College $2,252,479 under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through July 31, 2029. This R35 Maximizing Investigators' Research Award funds fundamental research investigating the mechanisms by which protein glycosylation regulates cell fate specification. The research employs zebrafish embryo models and loss-of-function studies to...
- Federal Project Grant Award Summary Dartmouth College received a $690,177 Project Grant from the National Science Foundation (NSF), Division of Molecular and Cellular Biosciences, under the Biological Sciences program (CFDA 47.074), awarded May 1, 2026, with completion targeted for April 30, 2030. This collaborative research project will deliver fundamental research outputs investigating how cells measure their nuclear-to-cytoplasmic (N/C) ratio to control the timing of zygotic genome activation...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Dartmouth College a $1.317 million Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective March 1, 2026, through February 28, 2030. This award supports fundamental research into the mechanisms of SWI/SNF (Switch/Sucrose Non-Fermentable) complex chromatin targeting selectivity. The research addresses a critical gap in understanding how mammalian SWI/SNF, a...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Dartmouth College a five-year Project Grant totaling $408,750 (awarded July 1, 2026; completion date June 30, 2031) under the Biomedical Research and Research Training program (CFDA 93.859) to develop photoswitchable hydrazone-based fluorescent dyes for super-resolution microscopy applications. The research addresses a critical gap in nanoscopy technology by engineering multifunctional,...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Trustees of Dartmouth College $408,750 under the Biomedical Research and Research Training program (CFDA 93.859) for a project beginning June 1, 2026, and concluding January 31, 2031. The project focuses on characterizing heme enzymes and their interacting proteins that function in electron-rich environments, with particular emphasis on bacterial redox enzyme systems operating under low-oxygen and...
- Federal Grant Award Summary Dartmouth College received an $883,252 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The award funds a five-year research initiative to develop a wireless, battery-free soft implant with a microneedle sensor array for continuous monitoring of organ physiology and biochemistry. The research addresses a critical...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $464,750 to the Mount Desert Island Biological Laboratory on March 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a project titled "Exploring Tissue-Specific Mechanisms and Requirements for Nucleolin Organization In Vivo." This five-year award, extending through January 31, 2031, funds basic research investigating the biological...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Massachusetts Institute of Technology (MIT) $438,788 in federal funding under the Biomedical Research and Research Training program (CFDA 93.859) beginning July 1, 2026 and concluding June 30, 2031. The project, titled "Microbial Manipulation of Eukaryotic Membranes," will deliver fundamental research findings on how pathogenic bacteria manipulate host cell membrane trafficking and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $613,838 to Fred Hutchinson Cancer Center on March 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to support investigator-initiated basic research on the mechanisms of dynamic cytoskeleton and membrane interactions. The five-year project, scheduled for completion on February 28, 2031, will establish the molecular framework underpinning cellular repair...
The National Institute of General Medical Sciences (NIGMS) awarded Dartmouth College $449,740 under the Biomedical Research and Research Training program (CFDA 93.859) effective August 1, 2026, through June 30, 2031. This Project Grant supports fundamental research investigating membrane and protein-dependent regulation of cortical patterning during cytokinesis—the cellular process by which dividing cells physically separate into two daughter cells. The research employs both in vitro reconstitution approaches using artificial cell cortex models comprised of supported lipid bilayers and Xenopus laevis egg cytoplasm, as well as complementary single-cell studies, to elucidate the biochemical and biophysical mechanisms underlying cortical excitability, a phenomenon characterized by traveling waves of filamentous actin assembly and disassembly during cell division. This basic research project addresses fundamental mechanisms of cell division essential to human development and tissue homeostasis. Understanding cortical remodeling dynamics has direct implications for disease states where cell growth and division are dysregulated, including cancer development associated with cytokinesis failure and resulting genomic defects such as aneuploidy. The research outputs will advance the broader scientific understanding of biological processes foundational to advances in disease diagnosis, treatment, and prevention, consistent with NIGMS's core mission in supporting investigator-initiated biomedical research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $449.7k | 7/14/26 |